Scientific Director, Obesity & Cardiometabolic Research

BioSpace; Lexington (MA); On-site; USD 200,000 - 290,000; Full time

Benefits offered by this job

Medical, dental, vision coverage

401(k) plan

Parental leave

Job summary

Novo Nordisk seeks a Scientific Director to lead obesity and cardiometabolic research programs in the US. You will shape scientific strategy, advance translational science, and drive high-impact collaborations across Global Research, Translational Medicine, and external partners.

Join a senior leadership team that defines portfolio direction, mentors researchers, and delivers decisive, data-driven decisions to accelerate discovery and clinical development in obesity and related diseases.

Qualifications

• Deep scientific expertise in cardiometabolic disease, obesity and co-morbidities, with translational research focus.
• Experience influencing drug discovery or development strategy in pharma/biotech environments.
• Proven ability to coordinate stakeholders and drive cross-functional execution.
• Excellent communication and strategic thinking for diverse audiences.

Responsibilities

• Lead scientific strategy for obesity and related co-morbidities; drive translational endpoints.
• Mentor teams and partner with external investigators and partners.
• Drive external innovation evaluations and due diligence for targets and platforms.
• Represent Novo Nordisk in scientific forums and collaborate across global sites.

Skills

Cardiometabolic

Translational research

Leadership

Stakeholder management

Cross-functional leadership

Scientific communication

Drug discovery

Education

PhD

MD/DO

Job description

Novo Nordisk seeks a Scientific Director to lead obesity and cardiometabolic research programs in the US. You will shape scientific strategy, advance translational science, and drive high-impact collaborations across Global Research, Translational Medicine, and external partners.

Join a senior leadership team that defines portfolio direction, mentors researchers, and delivers decisive, data-driven decisions to accelerate discovery and clinical development in obesity and related diseases.